Medical Device Investing Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
Medical Device Investing Medtronic to announce financial results for its second quarter of fiscal year 2026
Medical Device Investing U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyral renal denervation system
Medical Device Investing Medtronic BrainSense Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions
Medical Device Investing Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit
Medical Device Investing Medtronic initiates U.S. IDE clinical study evaluating Hugo robotic-assisted surgery system for gynecological procedures
Medical Device Investing Medtronic Announces Closing of Public Offering of Euro1.5 Billion of Senior Notes
Medical Device Investing Medtronic secures FDA approval for the Altaviva device, a simple experience for treating urge urinary incontinence
Medical Device Investing Medtronic initiates global pivotal study of cardiac pacing in a new patient population
medical device investing Medtronic achieves CE Mark approval for BrainSense Adaptive deep brain stimulation and Electrode Identifier, a groundbreaking advance in personalized, sensing-enabled care for people with Parkinson's through innovative brain-computer interface technology
Canadian Gold Resources to Expand Maiden Diamond Drill Program & Provides Update on Bulk Sampling Program at Lac Arsenault, LIFE Offering Update; Disclosure Corrections
Emerita Intersects 9.6 Meters Grading 2.7% Copper, 1.85 g/t Gold and 6.9 Meters Grading 1.4% Copper, 1.85 g/t Gold at El Cura Deposit
